The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Directly observed therapy for treating tuberculosis
Open accessAbstract
BACKGROUND: Tuberculosis (TB) requires at least six months of treatment. If treatment is incomplete, patients may not be cured and drug resistance may develop. Directly Observed Therapy (DOT) is a specific strategy, endorsed by the World Health Organization, to improve adherence by requiring health workers, community volunteers or family members to observe and record patients taking each dose. OBJECTIVES: To evaluate DOT compared to self-administered therapy in people on treatment for active TB or on prophylaxis to prevent active disease. We also compared the effects of different forms of DOT. SEARCH METHODS: We searched the following databases up to 13 January 2015: the Cochrane Infectious Diseases Group Specialized Register; the Cochrane Central Register of Controlled Trials (CENTRAL), published in the Cochrane Library; MEDLINE; EMBASE; LILACS and mRCT. We also checked article reference lists and contacted relevant researchers and organizations. SELECTION CRITERIA: Randomized controlled trials (RCTs) and quasi-RCTs comparing DOT with routine self-administration of treatment or prophylaxis at home. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed risk of bias of each included trial and extracted data. We compared interventions using risk ratios (RR) with 95% confidence intervals (CI). We used a random-effects model if meta-analysis was appropriate but heterogeneity present (I(2) statistic > 50%). We assessed the quality of the evidence using the GRADE approach. MAIN RESULTS: Eleven trials including 5662 participants met the inclusion criteria. DOT was performed by a range of people (nurses, community health workers, family members or former TB patients) in a variety of settings (clinic, the patient's home or the home of a community volunteer). DOT versus self-administered Six trials from South Africa, Thailand, Taiwan, Pakistan and Australia compared DOT with self-administered therapy for treatment. Trials included DOT at home by family members, community health workers (who were usually supervised); DOT at home by health staff; and DOT at health facilities. TB cure was low with self-administration across all studies (range 41% to 67%), and direct observation did not substantially improve this (RR 1.08, 95% CI 0.91 to 1.27; five trials, 1645 participants, moderate quality evidence). In a subgroup analysis stratified by the frequency of contact between health services in the self-treatment arm, daily DOT may improve TB cure when compared to self-administered treatment where patients in the self-administered group only visited the clinic every month (RR 1.15, 95% CI 1.06 to 1.25; two trials, 900 participants); but with contact in the control becoming more frequent, this small effect was not apparent (every two weeks: RR 0.96, 95% CI 0.83 to 1.12; one trial, 497 participants; every week: RR 0.90, 95% CI 0.68 to 1.21; two trials, 248 participants).Treatment completion showed a similar pattern, ranging from 59% to 78% in the self-treatment groups, and direct observation did not improve this (RR 1.07, 95% CI 0.96 to 1.19; six trials, 1839 participants, moderate quality evidence). DOT at home versus DOT at health facility In four trials that compared DOT at home by family members, or community health workers, with DOT by health workers at a health facility there was little or no difference in cure or treatment completion (cure: RR 1.02, 95% CI 0.88 to 1.18, four trials, 1556 participants, moderate quality evidence; treatment completion: RR 1.04, 95% CI 0.91 to 1.17, three trials, 1029 participants, moderate quality evidence). DOT by family member versus DOT by community health workerTwo trials compared DOT at home by family members with DOT at home by community health workers. There was also little or no difference in cure or treatment completion (cure: RR 1.02, 95% CI 0.86 to 1.21; two trials, 1493 participants, moderate quality evidence; completion: RR 1.05, 95% CI 0.90 to 1.22; two trials, 1493 participants, low quality evidence). Specific patient categoriesA trial of 300 intravenous drug users in the USA evaluated direct observation with no observation in TB prophylaxis to prevent active disease and showed little difference in treatment completion (RR 1.00, 95% CI 0.88 to 1.13; one trial, 300 participants, low quality evidence). AUTHORS' CONCLUSIONS: From the existing trials, DOT did not provide a solution to poor adherence in TB treatment. Given the large resource and cost implications of DOT, policy makers might want to reconsider strategies that depend on direct observation. Other options might take into account financial and logistical barriers to care; approaches that motivate patients and staff; and defaulter follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Interventions for promoting adherence to tuberculosis management
Volmink, J. A., & Garner, P. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000010 · Cited by 60
Self-citationRetractedAssessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,947
Bass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F., Snider, D. E., & Thornton, G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173779 · Cited by 1,193
Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Patient non-compliance: Deviance or reasoned decision-making?
Donovan, J. L., & Blake, D. R. (1992) · Social Science & Medicine · doi:10.1016/0277-9536(92)90206-6 · Cited by 785
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
When Tuberculosis Treatment Fails: A Social Behavioral Account of Patient Adherence
Sumartojo, E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1311 · Cited by 468
Isoniazid for preventing tuberculosis in non-HIV infected persons
Smieja, M., Marchetti, C., Cook, D., & Smaill, F. M. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001363 · Cited by 434
International standards of tuberculosis care.
Mohan, A. (2006) · PubMed · Cited by 432
International Standards for Tuberculosis Care
Hopewell, P. C., Pai, M., Maher, D., Uplekar, M., & Raviglione, M. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70628-4 · Cited by 336
Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis
Zwarenstein, M., Schoeman, J. H., Vundule, C., Lombard, C. J., & Tatley, M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04022-7 · Cited by 281
Directly observed therapy for tuberculosis: history of an idea
Bayer, R., Wilkinson, D., & Bayer, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91090-5 · Cited by 254
Walley, J. D., Khan, M. A., Newell, J. N., & Khan, M. H. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04129-5 · Cited by 230
Sepkowitz, K. A., Raffalli, J., Riley, L., Kiehn, T. E., & Armstrong, D. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.180 · Cited by 181
Directly observed therapy for treating tuberculosis
Volmink, J. A., & Garner, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub3 · Cited by 177
Self-citationThiam, S., LeFevre, A. M., Hane, F., Ndiaye, A., Ba, F., Fielding, K. L., Ndir, M., & Lienhardt, C. (2007) · JAMA · doi:10.1001/jama.297.4.380 · Cited by 175
Newell, J. N., Baral, S., Pande, S. B., Bam, D. S., & Malla, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68380-3 · Cited by 149
Wright, J., Walley, J. D., Philip, A. Z., Pushpananthan, S., Dlamini, E., Newell, J. N., & Dlamini, S. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01230.x · Cited by 147
Promoting adherence to treatment for tuberculosis: the importance of direct observation
Frieden, T. R. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038927 · Cited by 145
Bosch‐Capblanch, X., Abba, K., Prictor, M., & Garner, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004808.pub3 · Cited by 143
Self-citationThe problem of self-administration of drugs; with particular reference to pulmonary tuberculosis
Fox, W. (1958) · Tubercle · doi:10.1016/s0041-3879(58)80088-4 · Cited by 140
Volmink, J. A., & Garner, P. (1997) · BMJ · doi:10.1136/bmj.315.7120.1403 · Cited by 136
Self-citationAddington, W. W. (1979) · CHEST Journal · doi:10.1378/chest.76.6_supplement.741 · Cited by 134
Patient education and counselling for promoting adherence to treatment for tuberculosis
M’Imunya, J. M., Kredo, T., & Volmink, J. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006591.pub2 · Cited by 132
Khan, M. A., Walley, J. D., Witter, S. N., Imran, A., & Safdar, N. (2002) · Health Policy and Planning · doi:10.1093/heapol/17.2.178 · Cited by 130
Directly observed therapy for treating tuberculosis
Volmink, J. A., & Garner, P. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub2 · Cited by 128
Self-citationKamolratanakul, P., Sawert, H., Lertmaharit, S., Kasetjaroen, Y., Akksilp, S., Tulaporn, C., Punnachest, K., Na-Songkhla, S., & Payanandana, V. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90379-6 · Cited by 120
Pasipanodya, J. G., & Gumbo, T. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit167 · Cited by 119
Ford, N. P., Nachega, J. B., Engel, M. E., & Mills, E. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61671-8 · Cited by 114
Chaisson, R. E., Barnes, G. L., Hackman, J., Watkinson, L., Lucree Kimbrough, L. P. N., Metha, S. D., Cavalcante, S. C., & Moore, R. D. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00695-7 · Cited by 108
Abu, S. H., Medhin, G., Girma, B., Melese, M., Mekonen, A., Suarez, P. G., & Ameni, G. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-782 · Cited by 107
Enhancing Patient Compliance with Tuberculosis Therapy
Cuneo, W. D., & Snider, D. E. (1989) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00640-7 · Cited by 106
Tuberculosis Treatment Outcomes
Jasmer, R. M., Seaman, C. B., Jarlsberg, L. G., Kawamura, L. M., Osmond, D. H., & Daley, C. L. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-095oc · Cited by 103
Incentives vs outreach workers for latent tuberculosis treatment in drug users
Malotte, C. K., Hollingshead, J. R., & Larro, M. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00283-x · Cited by 97
Promoting adherence to tuberculosis treatment
Garner, P. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.035568 · Cited by 97
Self-citationClarke, M., Dick, J., Zwarenstein, M., Lombard, C. J., & Diwan, V. K. (2005) · PubMed · Cited by 77
Batki, S. L., Gruber, V. A., Bradley, J. M., Bradley, M., & Delucchi, K. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00208-3 · Cited by 75
Material incentives and enablers in the management of tuberculosis
Lutge, E. E., Wiysonge, C. S., Knight, S. E., & Volmink, J. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007952.pub2 · Cited by 66
Does directly observed therapy (DOT) reduce drug resistant tuberculosis?
Moonan, P. K., Quitugua, T. N., Pogoda, J. M., Woo, G., Drewyer, G., Sahbazian, B., Dunbar, D. F., Jost, K. C., Jr., Wallace, C. E., & Weis, S. E. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-19 · Cited by 64
Lewin, S. A., Dick, J., Zwarenstein, M., & Lombard, C. J. (2005) · Europe PMC (PubMed Central) · Cited by 64
Wandwalo, E. R., Kapalata, N., Egwaga, S., & Mørkve, O. (2004) · PubMed · Cited by 63
Zwarenstein, M., Schoeman, J., Vundule, C., Lombard, C. J., & Tatley, M. V. (2000) · PubMed · Cited by 61
Directly observed therapy for treating tuberculosis
Volmink, J. A., & Garner, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343 · Cited by 59
Self-citationLwilla, F., Schellenberg, D. M., Masanja, H., Acosta, C. J., Galindo, C. M., Aponte, J. J., Egwaga, S., Njako, B., Ascaso, C., Tanner, M., et al. (2003) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2003.00999.x · Cited by 56
Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Liu, Q., Abba, K., Alejandria, M. M., Balanag, V. M., Berba, R. P., & Lansang, M. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006594.pub2 · Cited by 55
Gross, R., Tierney, C., Andrade, A., Lalama, C., Rosenkranz, S., Eshleman, S. H., Flanigan, T., Santana, J., Salomon, N., Reisler, R., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.172 · Cited by 53
Directly Observed Therapy and Improved Tuberculosis Treatment Outcomes in Thailand
Anuwatnonthakate, A., Limsomboon, P., Nateniyom, S., Wattanaamornkiat, W., Komsakorn, S., Moolphate, S., Chiengsorn, N., Kaewsa-ard, S., Sombat, P., Siangphoe, U., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003089 · Cited by 48
MacIntyre, C. R., Goebel, K., Brown, G. V., Skull, S., Starr, M., & FULLINFAW, R. O. (2003) · PubMed · Cited by 40
Chien, J., Lai, C., Tan, C., Chien, S.-T., Yu, C., & Hsueh, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt103 · Cited by 35
Pungrassami, P., Johnsen, S. P., Chongsuvivatwong, V., & Olsen, J. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00849.x · Cited by 33
Managing medication compliance of tuberculosis patients in Haiti with medication monitors.
Moulding, T., & Caymittes, M. (2002) · PubMed · Cited by 31
An Exploration of Patient Perceptions of Adherence to Tuberculosis Treatment in Tanzania
van den Boogaard, J., Msoka, E., Homfray, M., Kibiki, G. S., Heldens, J., Felling, A., & Aarnoutse, R. E. (2012) · Qualitative Health Research · doi:10.1177/1049732312438968 · Cited by 29
Hsieh, C., Lin, L., Kuo, B. I., Chiang, C., Su, W., & Shih, J.-F. (2007) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2006.01924.x · Cited by 28
The cost-effectiveness of DOTS in urban Brazil.
Mohan, C. I., Bishai, D. M., Cavalcante, S. C., & Chaisson, R. E. (2007) · PubMed · Cited by 22
Tandon, M., Gupta, M., Tandon, S., & Gupta, K. B. (2002) · PubMed · Cited by 9
[Usefulness of directly observed therapy (DOT) during hospitalization as DOTS in Japanese style].
Toyota, E., Kobayashi, N., Houjou, M., Yoshizawa, A., Kawana, A., & Kudo, K. (2003) · PubMed · Cited by 7
Cited by
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
No health without mental health
Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61238-0 · Cited by 3,753
Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., Katoto, P. D. M. C., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.107 · Cited by 1,104
Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Conducting a meta-ethnography of qualitative literature: Lessons learnt
Atkins, S., Lewin, S., Smith, H., Engel, M., Fretheim, A., & Volmink, J. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-21 · Cited by 981
Metadata
- Authors
- Karumbi, J., & Garner, P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-05-29
- Volume
- 2015
- Issue
- 5
- Pages
- CD003343-CD003343
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2109728564
- Cited by
- 644
- References
- 58
- FWCI
- 38.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.